Research priorities in the management of hidradenitis suppurativa
Br J Dermatol
.
2023 Aug 24;189(3):343-345.
doi: 10.1093/bjd/ljad152.
Authors
Paul Leighton
1
,
Laura Howells
1
,
Janine Bates
2
,
Angela Gibbons
3
,
Rebecca Cannings-John
2
,
Fiona Collier
4
,
Judith Evans
2
,
Ceri Harris
3
,
Kerry Hood
2
,
Rachel Howes
5
,
Muhammad Riaz
2
,
Jeremy Rodrigues
6
7
,
Helen Stanton
2
,
Emma Thomas-Jones
2
,
Kim Thomas
1
,
John R Ingram
8
Affiliations
1
Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, NottinghamUK.
2
Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.
3
Public Contributors.
4
NHS Forth Valley, Stirling, UK.
5
Burns & Plastic Surgery, Stoke Mandeville Hospital, Aylesbury, UK.
6
Warwick Clinical Trials Unit, University of Warwick, Warwick, UK.
7
Dept of Plastic Surgery, Stoke Mandeville Hospital, Buckinghamshire Healthcare Trust, Aylesbury, UK.
8
Division of Infection & Immunity, Cardiff University, Cardiff, UK.
PMID:
37200410
DOI:
10.1093/bjd/ljad152
No abstract available
MeSH terms
Hidradenitis Suppurativa* / diagnosis
Hidradenitis Suppurativa* / therapy
Humans
Research
Grants and funding
17/90/01/National Institute of Health Research Health Technology Assessment